Plain-English translation of NCT05992532 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are trying to find out how often two rare genetic blood disorders—Gaucher disease and acid sphingomyelinase deficiency—are hiding in patients who have enlarged spleens or other blood cell problems. These disorders are often missed because their symptoms look like other, more common conditions. By testing patients' blood samples, the study aims to catch these rare diseases earlier.
Many patients come to doctors with an enlarged spleen or low blood platelets, but doctors can't figure out why. About 10–15% of these cases remain mysterious even after extensive testing. Recent research suggests that some of these mystery cases may actually be rare genetic disorders that no one thought to look for—and catching them early could help patients get the right treatment.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have a single blood sample taken using a special method called a dried blood spot test. The sample will be analyzed to check for the genetic markers and enzyme activity related to these rare disorders. The study does not involve taking any medication or returning for multiple visits—it's a straightforward screening test designed to help doctors understand whether a rare genetic disorder might explain your symptoms.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
Spain